Gray v. Cytokine Pharmasciences, Inc.

BVLaw
Full Text of Court Cases
April 25, 2002

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
It is also available in these products:
Already a subscriber or product owner?  Login
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
5122 Drugs, Drug Proprietaries, and Druggists' Sundries
424210 Drugs and Druggists' Sundries Merchant Wholesalers
shareholder dissent/oppression
shareholder dispute
Gray v. Cytokine Pharmasciences, Inc.
2002 Del. Ch. LEXIS 48
US
State Court
Delaware
Court of Chancery
Jeffrey B. Davis (for Gray)<br>J. Mark Penny (for Cytokine)<br>Merrill Lynch (for Cytokine)
Lamb

Summary

The issue in this case was the fair value of the shares of PharmaSciences, Inc.
Gray v. Cytokine Pharmasciences, Inc.
PDF, Size: 323 KB

See Also

Experts Rejected for Conflict of Interest and Failure to Use Management Projections

Legal and Court Case Update
July 2002

The issue in this case was the fair value of the shares of PharmaSciences Inc. (PSI).

This article also appears in:
BVR Guide to Management Projections and Business Valuation: Analysis and Case Law
Valuation Cases From the Delaware Court of Chancery Show How to Excel